26.9137 USD
-0.08 (-0.28%)
MTBCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. MTBCP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MTBCP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year MTBCP has reported negative net income.
- In the past year MTBCP had a positive cash flow from operations.
1.2 Ratios
- MTBCP has negative profitability rations, so we won't be analyzing them here.
- MTBCP has a Return On Invested Capital of 4.81%. This is amongst the best in the industry. MTBCP outperforms 84.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 4.81% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MTBCP's Operating Margin of 3.77% is fine compared to the rest of the industry. MTBCP outperforms 73.33% of its industry peers.
- MTBCP has a Gross Margin of 38.04%. This is in the lower half of the industry: MTBCP underperforms 66.67% of its industry peers.
- MTBCP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTBCP is destroying value.
- MTBCP has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for MTBCP is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 9.66 indicates that MTBCP is not in any danger for bankruptcy at the moment.
- MTBCP's Altman-Z score of 9.66 is amongst the best of the industry. MTBCP outperforms 88.89% of its industry peers.
- The Debt to FCF ratio of MTBCP is 0.06, which is an excellent value as it means it would take MTBCP, only 0.06 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.06, MTBCP belongs to the top of the industry, outperforming 82.22% of the companies in the same industry.
- A Debt/Equity ratio of 0.00 indicates that MTBCP is not too dependend on debt financing.
- MTBCP's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. MTBCP outperforms 64.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 9.66 |
ROIC/WACC0.6
WACC8.03%
2.3 Liquidity
- MTBCP has a Current Ratio of 1.21. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
- MTBCP has a worse Current ratio (1.21) than 73.33% of its industry peers.
- MTBCP has a Quick Ratio of 1.19. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of MTBCP (1.19) is worse than 71.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
- MTBCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.73%, which is quite impressive.
- MTBCP shows a small growth in Revenue. In the last year, the Revenue has grown by 7.14%.
- The Revenue has been growing by 41.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
3.2 Future
- The Earnings Per Share is expected to grow by 6.25% on average over the next years.
- MTBCP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- MTBCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year MTBCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- MTBCP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTBCP is cheaper than 84.44% of the companies in the same industry.
- MTBCP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTBCP is cheaper than 71.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.5 | ||
| EV/EBITDA | 23.41 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as MTBCP's earnings are expected to grow with 16.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%
5. Dividend
5.1 Amount
- No dividends for MTBCP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)
26.9137
-0.08 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03 2022-11-03/bmo
Earnings (Next)03-13 2023-03-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.85 | ||
| P/FCF | 46.5 | ||
| P/OCF | 19.3 | ||
| P/B | 3.98 | ||
| P/tB | 34.48 | ||
| EV/EBITDA | 23.41 |
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 4.81% | ||
| ROICexc | 4.99% | ||
| ROICexgc | 43.34% | ||
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 103.98% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 9.66 |
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A
CARECLOUD INC - MTBC 11 PERP / MTBCP FAQ
What is the ChartMill fundamental rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
ChartMill assigns a fundamental rating of 3 / 10 to MTBCP.
Can you provide the valuation status for CARECLOUD INC - MTBC 11 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CARECLOUD INC - MTBC 11 PERP (MTBCP). This can be considered as Overvalued.
Can you provide the profitability details for CARECLOUD INC - MTBC 11 PERP?
CARECLOUD INC - MTBC 11 PERP (MTBCP) has a profitability rating of 1 / 10.
What is the expected EPS growth for CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
The Earnings per Share (EPS) of CARECLOUD INC - MTBC 11 PERP (MTBCP) is expected to grow by 13.69% in the next year.